Information on this blog is being shared only for the purpose of creating legal awareness in public at large, especially in the field of Intellectual Property Right. As there may be possibility of error, omission or mistake in legal interpretation on the contents of this blog, it should not be treated as substitute for legal advise. [ADVOCATE AJAY AMITABH SUMAN, EMAIL: ajayamitabh7@gmail.com, Mob:09990389539]
Sunday, June 2, 2024
Anil Kumar Gera Vs Ramesh Chander
Thursday, May 30, 2024
Jitendra Kumar Vs The Registrar of Trademarks
Abstract:
This article examines the legal principles surrounding the rectification of a trademark registration based on prior use of a trade name. It focuses on a petition brought under Sections 47 and 57 of the Trademarks Act, 1999, aiming to cancel the registration of the trademark "WHITE BOY" granted to Respondent No. 2. The petitioner, who claims prior use of the trademark, challenges the registration on the grounds that their continuous use since 2010 establishes superior rights. This analysis explores the facts, findings, legal implications, ratio decidendi, and concludes with the case's significance in trademark law.
Facts:
The petitioner established a sole proprietorship, White Boy Apparels, in 2010, manufacturing and trading in shirts under the trademark "WHITE BOY." The petitioner claims continuous and uninterrupted use of the mark since its inception. On March 3, 2021, the petitioner applied for registration of the wordmark "WHITE BOY" in class 25, citing a user claim from January 10, 2013. However, Respondent No. 2 had already filed for the registration of the identical mark on March 2, 2021, one day before the petitioner's application.
Documentary evidence confirms the operation of 'White Boy Apparels' since 2010, though explicit use of the "WHITE BOY" trademark on products from 2010 to 2019 is not demonstrated. The petitioner supports their claim with tax invoices showing the sale of "WHITE BOY" shirts since 2020. In contrast, Respondent No. 2's application was on a proposed-to-be-used basis, with no evidence of actual use before or after registration.
Prior Use of Trade Name and Firm Name:
The petitioner has demonstrated a significant period of continuous use of the trade name "White Boy Apparels" since 2010, establishing goodwill and reputation associated with the name. The use of the trade name as a source identifier aligns with the definition of a trademark under Section 2(1)(m) and Section 2(1)(zb) of the Trademarks Act, 1999.
Lack of Evidence from Respondent No. 2:
Respondent No. 2's application was on a proposed-to-be-used basis, indicating no actual use of the mark "WHITE BOY" at the time of application.The absence of documentary proof of use by Respondent No. 2 weakens their claim to the trademark rights.
Commercial Use by Petitioner: Tax invoices submitted by the petitioner demonstrate active commercial use of the "WHITE BOY" mark since 2020, reinforcing their claim of continuous trademark usage.
Ratio Decidendi:
The decisive principle in this case is the doctrine of prior use. The petitioner’s established and continuous use of the "WHITE BOY" mark since 2010, combined with the lack of actual use by Respondent No. 2, establishes the petitioner’s superior rights. The court's reliance on documentary evidence, such as tax invoices and the longstanding operation of 'White Boy Apparels,' underscores the importance of proving continuous and substantive use in trademark disputes.
Concluding Note:
The cancellation of the trademark "WHITE BOY" under No. 4886714 in class 25 emphasizes the critical role of prior use in trademark law. This case reaffirms that mere filing of a trademark application on a proposed-to-be-used basis does not outweigh established prior use. The decision underscores the necessity for businesses to maintain thorough records of their trademark use to support their claims in potential disputes.
Case Title: Jitendra Kumar Vs The Registrar of Trademarks
Order Date: 28.05.2024
Case No. C.O. (COMM.IPD-TM) 92/2023
Neutral Citation:2024:DHC:4402
Name of Court: Delhi High Court
Name of Hon'ble Judge: Sanjeev Narula. H.J.
Disclaimer:
Ideas, thoughts, views, information, discussions and interpretation expressed herein are being shared in the public Interest. Readers' discretion is advised as these are subject to my subjectivity and may contain human errors in perception, interpretation and presentation of the fact and issue involved herein.
Written By: Advocate Ajay Amitabh Suman
IP Adjutor [Patent and Trademark Attorney]
United & United
Email: amitabh@unitedandunited.com
Ph No: 9990389539
Macleods Pharmaceuticals Limited Vs Alkem Laboratories Ltd. and another
Abstract:
This legal analysis examines a trademark dispute involving the plaintiff's mark ‘ALRISTA’ and the defendant's mark ‘ALSITA’. Both marks pertain to pharmaceutical formulations used in diabetes-related treatments. The plaintiff's mark, ‘ALRISTA’, is associated with the drug ‘EPALRESTAT’, used for diabetic neuropathy, while the defendant's mark, ‘ALSITA’, is associated with ‘SITAGLIPTIN’, used for treating Type 2 diabetes.
The primary legal issue revolves around the likelihood of confusion between the two marks and the potential public health implications. This analysis explores the facts, findings, legal implications, ratio decidendi, and concludes with a summary of the case’s significance.
Facts:
The plaintiff has been using the mark ‘ALRISTA’ since 2007 and applied for registration under application No.1585338, in Class 5, on July 30, 2007. This application is currently under opposition. The defendant adopted the mark ‘ALSITA’ in 2021, applied for registration via application No.4969725 on May 10, 2021, and obtained registration on October 31, 2021. The plaintiff claims that the defendant's use of ‘ALSITA’ for a formulation containing ‘SITAGLIPTIN’ is likely to cause confusion with their mark ‘ALRISTA’ used for a formulation containing ‘EPALRESTAT’.
Findings:
Upon analyzing the phonetic and structural similarities between ‘ALRISTA’ and ‘ALSITA’, it is evident that the two marks are remarkably similar. Both marks consist of similar letters arranged in a similar sequence, leading to a high probability of confusion among consumers and healthcare professionals. Considering that both drugs are prescribed to diabetic patients, albeit for different indications, the potential for disastrous consequences if the wrong medication is dispensed is significant. This risk is heightened in the pharmaceutical context, where even minor errors can have severe health implications.
Legal Implications:
The primary legal principle at stake is the doctrine of passing off, which protects the goodwill of a trader from misrepresentation leading to consumer confusion. Since the plaintiff's mark is not yet registered, the action is based on passing off rather than trademark infringement. The court must determine whether the defendant's use of ‘ALSITA’ constitutes a misrepresentation that could lead to consumer confusion, damaging the plaintiff's goodwill and causing potential harm to patients.
Ratio Decidendi:
The key legal precedent applicable here is the necessity to avoid confusion in the pharmaceutical sector due to the potential for serious health risks. The court in *Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd.* emphasized that even a remote possibility of confusion in medicinal products warrants restraint. This principle is particularly relevant in this case, where the marks ‘ALRISTA’ and ‘ALSITA’ are used for drugs targeting diabetic patients, albeit for different conditions. Given the phonetic and structural similarities, the likelihood of confusion is substantial.
Concluding Note:
In conclusion, the court's primary concern in this case is the potential for confusion between ‘ALRISTA’ and ‘ALSITA’ and the consequent risk to patient safety. The similarities between the marks, coupled with their use in diabetes-related treatments, underscore the need for careful scrutiny to prevent misprescription or dispensing errors. The legal framework and judicial precedents support the plaintiff's contention that even the slightest probability of confusion in medicinal products is unacceptable. Therefore, it is imperative to restrain the use of the defendant's mark ‘ALSITA’ to safeguard public health and uphold the principles of fair competition and consumer protection.
Case Title: Macleods Pharmaceuticals Limited Vs Alkem Laboratories Ltd. and another
Order Date: 28.05.2024
Case No. CS Comm 86 of 2024
Neutral Citation:2024:DHC:4432
Name of Court: Delhi High Court
Name of Hon'ble Judge: Anish Dayal. H.J.
Disclaimer:
Ideas, thoughts, views, information, discussions and interpretation expressed herein are being shared in the public Interest. Readers' discretion is advised as these are subject to my subjectivity and may contain human errors in perception, interpretation and presentation of the fact and issue involved herein.
Written By: Advocate Ajay Amitabh Suman
IP Adjutor [Patent and Trademark Attorney]
United & United
Email: amitabh@unitedandunited.com
Ph No: 9990389539
Laverana GMBH Vs MAC Personal Care Pvt. Ltd.
Introduction:
This article delves into Chamber appeal against an order dated October 16, 2017, issued by the Joint Registrar. The appeal challenges objections raised by the defendants regarding the admissibility of certain documents presented by the plaintiff and the refusal to accept a Certificate under Section 65B of the Evidence Act, 1872.
The Delhi High Court, referencing the judgment in *Eli Lilly & Co. vs. Maiden Pharmaceuticals Ltd.* (2016) 235 DLT 381, has subsequently taken the Certificate on record. This case presents significant questions regarding the procedural and substantive aspects of digital evidence admissibility under Indian law.
Section 65B of the Evidence Act, 1872:
Section 65B addresses the admissibility of electronic records. According to this provision, any information contained in an electronic record, which is printed on paper, stored, recorded, or copied, shall be deemed to be a document admissible in any proceedings, provided certain conditions are met.
Subsection (4) mandates that a certificate, identifying the electronic record containing the statement and describing the manner in which it was produced, must accompany the document. This certificate should be signed by a responsible official, providing assurance of the document's authenticity and the reliability of the electronic process.
Judicial Precedents:
Eli Lilly & Co. Vs. Maiden Pharmaceuticals Ltd. established that the Certificate under Section 65B could be filed along with the affidavit by way of examination-in-chief. This ruling underscores a flexible approach, allowing for the certificate to be submitted at a later stage in the proceedings, ensuring that substantive justice is not hindered by procedural technicalities.
Facts and Procedural History:
The plaintiff, in the present case, attempted to introduce certain documents into evidence, purportedly meeting the requirements of Section 65B. However, the Joint Registrar rejected these documents, citing non-compliance with the statutory prerequisites. Specifically, the Joint Registrar refused to accept the Certificate under Section 65B, which was presented at a later stage. The plaintiff's appeal to the High Court questioned the rigidity of this refusal and sought a more lenient interpretation in line with the Eli Lilly precedent.
Implication:
The Chamber appeal highlights a critical aspect of modern legal proceedings: the admissibility of electronic evidence and the procedural requirements governing it. The Delhi High Court's decision to accept the Certificate under Section 65B of the Evidence Act, 1872, in light of the *Eli Lilly* judgment, signifies a progressive step towards a more flexible and just legal process.
Conclusion:
While statutory compliance is indispensable, courts must also ensure that such compliance does not become a barrier to the administration of justice. The acceptance of Section 65B certificates at a later stage, as upheld in this appeal, exemplifies a balanced and fair approach, promoting the integrity and efficacy of the judicial process.
Case Title: Laverana GMBH Vs MAC Personal Care Pvt. Ltd.
Order Date: 28.02.2018
Case No. CS Comm 122 of 2018
Neutral Citation:NA
Name of Court: Delhi High Court
Name of Hon'ble Judge: Rajiv Sahai Endlaw. H.J.
Disclaimer:
Ideas, thoughts, views, information, discussions and interpretation expressed herein are being shared in the public Interest. Readers' discretion is advised as these are subject to my subjectivity and may contain human errors in perception, interpretation and presentation of the fact and issue involved herein.
Written By: Advocate Ajay Amitabh Suman
IP Adjutor [Patent and Trademark Attorney]
United & United
Email: amitabh@unitedandunited.com
Ph No: 9990389539
Tuesday, May 28, 2024
Lotus Organic Care Vs Aadhar Products
KRBL Vs John Doe and another
Fab India Vs Fab India Emporium
Fact:
Fabindia, incorporated in 1960, is a leading Indian retail company specializing in handcrafted goods. It operates numerous retail outlets across major Indian cities and has a significant online presence. Fabindia has secured over 100 trademark registrations for its name 'FABINDIA'.
Recently, Fab India Emporium, a new retail store in Delhi, began selling similar products under a name that closely resembles Fabindia's trademark. Fabindia alleges that this causes consumer confusion and dilutes its brand.
Finding:
The Court's findings supporting the ex-parte ad interim injunction in favor of Fabindia include:
Trademark Strength:
Fabindia's trademark 'FABINDIA' is widely recognized, with over 100 registrations and a longstanding presence in the market.
Likelihood of Confusion:
The defendant's use of "Fab India Emporium" is similar enough to Fabindia's trademark to likely cause consumer confusion.
Balance of Convenience:
The potential harm to Fabindia’s established reputation and business outweighs any inconvenience the defendant might face due to the injunction.
Irreparable Harm:
Without the injunction, Fabindia risks significant harm, including brand dilution and loss of consumer trust, which cannot be adequately compensated through monetary means.
Ratio:
The Court’s rationale for granting the injunction is based on the following points:
Prima Facie Case:
Fabindia has demonstrated a substantial likelihood of success in proving trademark infringement, showing that the defendant’s similar name is likely to deceive consumers.
Balance of Convenience:
The balance of convenience favors Fabindia, as the harm to its reputation and business is greater than any inconvenience to the defendant.
Irreparable Harm:
Fabindia faces irreparable harm if the injunction is not granted, including potential loss of brand distinctiveness and consumer trust, which monetary compensation cannot rectify.
Case Title: Fab India Vs Fab India Emporium
Order Date: 15.05.2024
Case No. CS(COMM) 394/2024,
Neutral Citation:NA
Name of Court: Delhi High Court
Name of Hon'ble Judge: Anish Dayal. H.J.
Disclaimer:
Ideas, thoughts, views, information, discussions and interpretation expressed herein are being shared in the public Interest. Readers' discretion is advised as these are subject to my subjectivity and may contain human errors in perception, interpretation and presentation of the fact and issue involved herein.
Written By: Advocate Ajay Amitabh Suman
IP Adjutor [Patent and Trademark Attorney]
United & United
Email: amitabh@unitedandunited.com
Ph No: 9990389539
Monday, May 27, 2024
Elli Lilly and Company Vs Maiden Pharmaceutical Limited
Sunday, May 26, 2024
Sanjay Gupta Vs Anil Udyog
Blog Archive
- January 2025 (40)
- October 2024 (8)
- September 2024 (34)
- August 2024 (68)
- July 2024 (39)
- June 2024 (57)
- May 2024 (49)
- April 2024 (6)
- March 2024 (44)
- February 2024 (39)
- January 2024 (21)
- December 2023 (29)
- November 2023 (23)
- October 2023 (29)
- September 2023 (33)
- August 2023 (29)
- July 2023 (29)
- June 2023 (2)
- May 2023 (1)
- April 2023 (5)
- March 2023 (6)
- February 2023 (1)
- November 2022 (17)
- October 2022 (11)
- September 2022 (30)
- August 2022 (47)
- July 2022 (37)
- June 2022 (26)
- October 2020 (1)
- September 2020 (1)
- April 2020 (1)
- March 2020 (1)
- February 2020 (2)
- December 2019 (1)
- September 2019 (3)
- August 2019 (2)
- July 2019 (1)
- June 2019 (2)
- April 2019 (3)
- March 2019 (2)
- February 2019 (2)
- January 2019 (2)
- December 2018 (3)
- November 2018 (1)
- October 2018 (2)
- September 2018 (2)
- August 2018 (8)
- July 2018 (2)
- June 2018 (1)
- May 2018 (41)
- April 2018 (7)
- March 2018 (3)
- February 2018 (4)
- January 2018 (2)
- December 2017 (6)
- November 2017 (4)
- September 2017 (5)
- August 2017 (6)
- July 2017 (1)
- June 2017 (1)
- May 2017 (10)
- April 2017 (16)
- November 2016 (3)
- October 2016 (24)
- March 2015 (2)
- January 2014 (1)
- December 2013 (4)
- October 2013 (2)
- September 2013 (7)
- August 2013 (27)
- May 2013 (7)
- September 2012 (31)
- December 2009 (3)
- September 2009 (1)
- March 2009 (3)
- January 2009 (2)
- December 2008 (1)
Featured Post
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING
WHETHER THE REGISTRAR OF TRADEMARK IS REQUIRED TO BE SUMMONED IN A CIVIL SUIT TRIAL PROCEEDING IN ORDER TO PROVE THE TRADEMARK REGISTRA...
-
$~5 * IN THE HIGH COURT OF DELHI AT NEW DELHI + FAO 317/2018, CAV 617/2018 & CM AP...
-
==================== Judgement Date:29.08.2022 Case No. CM (M) IPD 2 of 2022 Hon'ble High Court of Delhi Prathiba M Singh, H.J. Institu...
My Blog List
-
मछलियों में घड़ियाल - गीता-विà¤ूति योग श्रीà¤à¤—वानुवाच “प्रह्लादश्चास्मि दैत्यानां कालः कलयतामहम्। मृगाणां च मृगेन्द्रोऽहं वैनतेयश्च पक्षिणाम्।।” मैं दैत्यों में प्रह्लाद और ग...2 weeks ago
-
Deepfake Technology: Unveiling The Challenges And Protective Measures - Introduction: The rapid evolution of technology has propelled humanity into an era of unprecedented progress and connectivity. However, as with any doubl...1 year ago
-
-
My other Blogging Links
- Ajay Amitabh Suman's Poem and Stories
- Facebook-My Judgments
- Katha Kavita
- Lawyers Club India Articles
- My Indian Kanoon Judgments
- Linkedin Articles
- Speaking Tree
- You Tube-Legal Discussion
- बेनाम कोहड़ा बाजारी -Facebook
- बेनाम कोहड़ा बाजारी -वर्ड प्रेस
- बेनाम कोहड़ा बाजारी-दैनिक जागरण
- बेनाम कोहड़ा बाजारी-नवà¤ारत टाइम्स
- बेनाम कोहड़ा बाजारी-ब्लॉग स्पॉट
- बेनाम कोहड़ा बाजारी-स्पीकिंग ट्री